pH-responsive R848-loaded Cu MOF NPs potentiate anti-tumor immunity via synergistic photothermal therapy and immunotherapy in hepatocellular carcinoma
Hepatocellular carcinoma (HCC), the most common type of liver cancer, remains a major cause of cancer-related mortality worldwide, with limited treatment options and poor prognosis in advanced stages. Immunotherapy has shown promise in treating advanced HCC, with the TLR7/8 agonist resiquimod (R848) effectively activat...